Evidence map›Paper›PMID 22080269›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2011

Trichomonas vaginalis genital infections: progress and challenges.

Laura H Bachmann, Marcia M Hobbs, Arlene C Seña, Jack D Sobel, Jane R Schwebke, John N Krieger, R Scott McClelland, Kimberly A Workowski

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. A review onSouthern African journal of infectious diseases · 2021
    Review
  6. Advancing Prevention of STIs by Developing Specific Serodiagnostic Targets:International journal of environmental research and public health · 2020
    Article
  7. Article
  8. Article
  9. A Study ofJournal of parasitology research · 2019
    Article
  10. Article
  11. Why Does Trichomonas vaginalis Continue to be a "Neglected" Sexually Transmitted Infection?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Prevalence ofJournal of clinical and diagnostic research : JCDR · 2016
    Article
  16. Article
  17. Trichomonas vaginalis PREVALENCE AND RISK FACTORS FOR WOMEN IN SOUTHERN BRAZIL.Revista do Instituto de Medicina Tropical de Sao Paulo · 2016
    Article
  18. Article
  19. Review
  20. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Laura H BachmannInfectious Diseases, Wake Forest University Health Sciences, Medical Center Blvd, Winston-Salem, NC 27157, USA. lbachman@wfubmc.edu
Marcia M Hobbs
Arlene C Seña
Jack D Sobel
Jane R Schwebke
John N Krieger
R Scott McClelland
Kimberly A Workowski
University of Washington · USBipar · FREmory University · USUniversity of Alabama at Birmingham · USUniversity of North Carolina at Chapel Hill · USWayne State University · USW. G. (Bill) Hefner VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trichomonas vaginalis (TV) infection is the most prevalent curable sexually transmitted infection in the United States and worldwide. Most TV infections are asymptomatic, and the accurate diagnosis of this infection has been limited by lack of sufficiently sensitive and specific diagnostic tests, particularly for men. To provide updates for the 2010 Centers for Disease Control and Prevention's Sexually Transmitted Diseases Treatment Guidelines, a PubMed search was conducted of all TV literature published from 9 January 2004 through 24 September 2008. Approximately 175 pertinent abstracts and articles were reviewed and discussed with national experts. This article describes advances in TV diagnostics which have led to an improved understanding of the epidemiology of this pathogen, as well as potential biologic and epidemiological interactions between TV and human immunodeficiency virus (HIV). New data on treatment outcomes, metronidazole-resistant TV, management of nitroimidazole-allergic patients, frequency of recurrent TV infection following treatment, and screening considerations for TV in certain populations are also presented.

Indexed as

AdolescentAdultAntiprotozoal AgentsDrug HypersensitivityDrug ResistanceFemaleGenital Diseases, FemaleGenital Diseases, MaleHIV InfectionsHumansMaleMass ScreeningMiddle AgedPractice Guidelines as TopicRecurrenceTrichomonas InfectionsAntiprotozoal Agents

Identifiers

PMID22080269
PMCPMC3897282
OpenAlexW2090371402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.